{"success":true,"data":{"pressRelease":{"id":"140901","rtpr_id":"nPn7TcSzra-20260910","ticker":"ABBV","exchange":"NYSE","all_tickers":["ABBV"],"title":"AbbVie Declares Quarterly Dividend","author":"PR Newswire","published_at":"2026-09-10T18:18:30.405Z","article_body":"AbbVie Declares Quarterly Dividend\n\nPR Newswire\n\nNORTH CHICAGO, Ill., Sept. 10, 2026\n\nNORTH CHICAGO, Ill., Sept. 10, 2026 /PRNewswire/ -- The board of directors of\nAbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per\nshare.\n\nThe cash dividend is payable November 16, 2026, to stockholders of record at\nthe close of business on October 15, 2026.\n\nSince the company's inception in 2013, AbbVie has increased its dividend by\nmore than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats\nIndex, which tracks companies that have annually increased their dividend for\nat least 25 consecutive years.\n\nAbout AbbVie\n\nAbbVie's mission is to discover and deliver innovative medicines and solutions\nthat solve serious health issues today and address the medical challenges of\ntomorrow. We strive to have a remarkable impact on people's lives across\nseveral key therapeutic areas including immunology, neuroscience and oncology\n– and products and services in our Allergan Aesthetics portfolio. For more\ninformation about AbbVie, please visit us at www.abbvie.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=2231181977&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D3341195671%26u%3Dhttps%253A%252F%252Fwww.abbvie.com%252F%26a%3Dwww.abbvie.com&a=www.abbvie.com)\n. Follow @abbvie on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=2581564726&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D3642356964%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fabbvie%252F%26a%3DLinkedIn&a=LinkedIn)\n, Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=3481707583&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D4090909078%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252FAbbVieGlobal%252F%26a%3DFacebook&a=Facebook)\n, Instagram\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=690420444&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D2951812016%26u%3Dhttps%253A%252F%252Fwww.instagram.com%252Fabbvie%252F%26a%3DInstagram&a=Instagram)\n, X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=427749621&u=https%3A%2F%2Fx.com%2Fabbvie&a=X)\n and YouTube\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=266992792&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D1780321981%26u%3Dhttps%253A%252F%252Fwww.youtube.com%252Fuser%252FAbbVie%26a%3DYouTube&a=YouTube)\n.\n Media:                                                            Investors:\n Catherine Langel                                                  Liz Shea\n (708) 508-3524                                                    (847) 935-2211\n catherine.langel@abbvie.com (mailto:catherine.langel@abbvie.com)  liz.shea@abbvie.com (mailto:liz.shea@abbvie.com)\n\n \n\nView original\ncontent:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302875664.html\n(https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302875664.html)\n\nSOURCE AbbVie\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn7TcSzra-20260910","title":"AbbVie Declares Quarterly Dividend","author":"PR Newswire","ticker":"ABBV","created":"2026-09-10T18:18:30.405Z","tickers":["ABBV"],"exchange":"NYSE","article_body":"AbbVie Declares Quarterly Dividend\n\nPR Newswire\n\nNORTH CHICAGO, Ill., Sept. 10, 2026\n\nNORTH CHICAGO, Ill., Sept. 10, 2026 /PRNewswire/ -- The board of directors of\nAbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per\nshare.\n\nThe cash dividend is payable November 16, 2026, to stockholders of record at\nthe close of business on October 15, 2026.\n\nSince the company's inception in 2013, AbbVie has increased its dividend by\nmore than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats\nIndex, which tracks companies that have annually increased their dividend for\nat least 25 consecutive years.\n\nAbout AbbVie\n\nAbbVie's mission is to discover and deliver innovative medicines and solutions\nthat solve serious health issues today and address the medical challenges of\ntomorrow. We strive to have a remarkable impact on people's lives across\nseveral key therapeutic areas including immunology, neuroscience and oncology\n– and products and services in our Allergan Aesthetics portfolio. For more\ninformation about AbbVie, please visit us at www.abbvie.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=2231181977&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D3341195671%26u%3Dhttps%253A%252F%252Fwww.abbvie.com%252F%26a%3Dwww.abbvie.com&a=www.abbvie.com)\n. Follow @abbvie on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=2581564726&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D3642356964%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fabbvie%252F%26a%3DLinkedIn&a=LinkedIn)\n, Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=3481707583&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D4090909078%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252FAbbVieGlobal%252F%26a%3DFacebook&a=Facebook)\n, Instagram\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=690420444&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D2951812016%26u%3Dhttps%253A%252F%252Fwww.instagram.com%252Fabbvie%252F%26a%3DInstagram&a=Instagram)\n, X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=427749621&u=https%3A%2F%2Fx.com%2Fabbvie&a=X)\n and YouTube\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4770516-1&h=266992792&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4610190-1%26h%3D1780321981%26u%3Dhttps%253A%252F%252Fwww.youtube.com%252Fuser%252FAbbVie%26a%3DYouTube&a=YouTube)\n.\n Media:                                                            Investors:\n Catherine Langel                                                  Liz Shea\n (708) 508-3524                                                    (847) 935-2211\n catherine.langel@abbvie.com (mailto:catherine.langel@abbvie.com)  liz.shea@abbvie.com (mailto:liz.shea@abbvie.com)\n\n \n\nView original\ncontent:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302875664.html\n(https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302875664.html)\n\nSOURCE AbbVie\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-10T18:18:30.438436823Z","server_sent_at_ms":1789064310438},"received_at":"2026-09-10T18:18:30.493Z","source_url":"https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302875664.html"},"analysis":{"id":"129737","press_release_id":"140901","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":[],"eventType":"dividend","narrative":"AbbVie's board declared a quarterly cash dividend of $1.73 per share, payable November 16, 2026, to stockholders of record at the close of business on October 15, 2026.\n\nSince its 2013 inception, AbbVie has increased its dividend by more than 330 percent, and the company remains a member of the S&P Dividend Aristocrats Index, which tracks firms with at least 25 consecutive years of annual dividend increases.\n\nThis is a routine maintenance of the current payout rate with no increase announced — meaningful for income-focused holders but carrying no surprise for the stock.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine ABBV dividend declaration confirms the income stream at an unchanged $1.73 rate — no action needed."},"keyFigures":{"customDimensions":{"dividend_per_share":1.73,"dividend_record_date":"2026-10-15","dividend_payment_date":"2026-11-16","dividend_growth_since_2013_inception":"more than 330 percent"}},"namedEntities":{"people":[{"name":"Catherine Langel","role":"Media contact"},{"name":"Liz Shea","role":"Investor relations contact"}],"products":["Allergan Aesthetics"],"companies":[{"name":"AbbVie Inc.","ticker":"ABBV","relationship":"filer"}],"dollarAmounts":[{"amount":"$1.73","context":"quarterly cash dividend per share"}]},"materialImpact":{"score":1,"reasoning":"Routine quarterly dividend declaration at the existing $1.73 per share rate with payment and record dates; no increase, cut, or new capital-allocation information. Boilerplate for a mega-cap Dividend Aristocrat."},"tickerRelevance":{"others":[],"primary":"ABBV"},"globalImportance":18,"audienceRelevance":50,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mega-cap S&P 100 household name","eventGravity":"routine quarterly dividend declaration, unchanged rate, no increase","sectorWeight":"Health Care / large-cap pharma","isDividendIncrease":false,"dividendAristocratStatus":true}},"event_type":"dividend","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"AbbVie's board declared a quarterly cash dividend of $1.73 per share, payable November 16, 2026, to stockholders of record at the close of business on October 15, 2026.\n\nSince its 2013 inception, AbbVie has increased its dividend by more than 330 percent, and the company remains a member of the S&P Dividend Aristocrats Index, which tracks firms with at least 25 consecutive years of annual dividend increases.\n\nThis is a routine maintenance of the current payout rate with no increase announced — meaningful for income-focused holders but carrying no surprise for the stock.","key_figures":{"customDimensions":{"dividend_per_share":1.73,"dividend_record_date":"2026-10-15","dividend_payment_date":"2026-11-16","dividend_growth_since_2013_inception":"more than 330 percent"}},"named_entities":{"people":[{"name":"Catherine Langel","role":"Media contact"},{"name":"Liz Shea","role":"Investor relations contact"}],"products":["Allergan Aesthetics"],"companies":[{"name":"AbbVie Inc.","ticker":"ABBV","relationship":"filer"}],"dollarAmounts":[{"amount":"$1.73","context":"quarterly cash dividend per share"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-10T18:19:00.904Z","global_importance":18,"audience_relevance":50,"importance_components":{"tickerTier":"mega-cap S&P 100 household name","eventGravity":"routine quarterly dividend declaration, unchanged rate, no increase","sectorWeight":"Health Care / large-cap pharma","isDividendIncrease":false,"dividendAristocratStatus":true}},"durationMs":30402,"modelName":"glm-5.3-flash"}}